Venatorx Pharmaceuticals (Series B)

Funding Details
Awarder
Inbox
Date Award
July 26, 2017
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$42,000,000

Company Info
Founders
Christopher Burns, Ph.D.
Company Description
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Market
Antibiotic resistance treatment
Location
Malvern, PA, USA
Coinvestors
Abingworth, Foresite Capital, Versant Ventures

Links